Conclusion of a Non-Exclusive Discount Agreement Tender

• Country: Germany
• Summary: Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Rivaroxaban (Atc Code: B01af01).
• DET Ref No: 97068560
• Deadline: 25 Jan 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 99749-2024
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Conclusion of a non-exclusive discount contract in accordance with Section 130a Paragraph 8 SGB V for drugs with the active ingredient rivaroxaban (ATC code: B01AF01) within the period from April 1st, 2024 to March 31st, 2026 with the possibility of concluding the contract at any time during the term ("open- house model").
  ToAOK Niedersachsen offers the active ingredient rivaroxaban (ATC code: B01AF01). The health insurance fund for the period up to the entry into force of exclusive contracts as a result of a formal award procedure in accordance with the regulations of Part 4 of the GWB to all interested pharmaceutical companies, withoutSelection decision, discount contracts. The contracts are concluded as part of an "open-house model" and act as a bridge between the start of generic competition (patent expiry) and the award of exclusive contracts. The contracts offered are not exclusive; Contracts with aAll market participants (pharmaceutical companies) are desired by AOK Niedersachsen. In the open-house model, uniform conditions apply to all participants. Contract contents, conditions and access procedures are uniform - individual negotiations are generally not permittedhrt. The contract terms are a maximum of twenty-four months; the earliest contract start date is April 1, 2024. All contracts end on March 31, 2026 at the latest, regardless of the date of conclusion of the respective contract. Joining or concluding a contract can be done within the twenty-four month period...
• Documents:

 Tender Notice